Table 5 Sensitivities, specificities, positive predictive values, and negative predictive values of clinical prediction tool for pre-treatment HIV RNA <100,000 copies/mL among validation patients with data on all included variables (n = 587)

From: Factors associated with pre-treatment HIV RNA: application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settings